ZBH · Business segments
Zimmer Biomet (ZBH) revenue by segment
Where Zimmer Biomet’s revenue comes from, as reported in its SEC filings.
Latest quarter: June 30, 2026
Total revenue on the income statement: $2.18B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| Americas | $1.36B | 62.4% |
| EMEA | $478.5M | 22.0% |
| Asia Pacific | $339.5M | 15.6% |
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Knees | $828.9M | 38.1% |
| SET | $586M | 26.9% |
| Hips | $562.7M | 25.8% |
| Technology and Data, Bone Cement and Surgical | $199.4M | 9.2% |
Latest year: December 31, 2025
Total revenue on the income statement: $8.23B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| Americas | $5.14B | 62.5% |
| EMEA | $1.83B | 22.2% |
| Asia Pacific | $1.26B | 15.3% |
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Knees | $3.32B | 40.4% |
| SET | $2.15B | 26.1% |
| Hips | $2.09B | 25.4% |
| Technology and Data, Bone Cement and Surgical | $665.6M | 8.1% |
Reading notes
Share is each line’s part of that breakdown. Margin is the company’s reported segment operating income divided by that segment’s revenue. Companies define segment profit differently and may re-cut segments over time, so a company’s lines can differ between years. Breakdowns that do not add up to within 5% of reported revenue are left out.